Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
ARDX

ARDX - Ardelyx Inc Stock Price, Fair Value and News

5.51USD+0.02 (+0.36%)Market Closed

Market Summary

ARDX
USD5.51+0.02
Market Closed
0.36%

ARDX Alerts

  • 2 major insider sales recently.

ARDX Stock Price

View Fullscreen

ARDX RSI Chart

ARDX Valuation

Market Cap

1.3B

Price/Earnings (Trailing)

-19.59

Price/Sales (Trailing)

8.1

EV/EBITDA

-21.93

Price/Free Cashflow

-15.89

ARDX Price/Sales (Trailing)

ARDX Profitability

Operating Margin

96.50%

EBT Margin

-40.95%

Return on Equity

-43.62%

Return on Assets

-19.22%

Free Cashflow Yield

-6.29%

ARDX Fundamentals

ARDX Revenue

Revenue (TTM)

159.1M

Rev. Growth (Yr)

304.81%

Rev. Growth (Qtr)

33.93%

ARDX Earnings

Earnings (TTM)

-65.8M

Earnings Growth (Yr)

0.95%

Earnings Growth (Qtr)

7.93%

Breaking Down ARDX Revenue

Last 7 days

-6.4%

Last 30 days

-7.4%

Last 90 days

-15.0%

Trailing 12 Months

61.1%

How does ARDX drawdown profile look like?

ARDX Financial Health

Current Ratio

4.53

ARDX Investor Care

Shares Dilution (1Y)

9.10%

Diluted EPS (TTM)

-0.28

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024159.1M000
202363.1M82.9M134.3M124.5M
20224.0M5.2M9.0M52.2M
202112.9M12.4M10.9M10.1M
20206.6M8.3M8.0M7.6M
2019003.3M5.5M
201844.3M44.4M44.5M2.6M
201700060.1M
201529.0M38.0M30.4M24.0M
201430.9M32.8M33.8M31.6M
201311.3M17.2M23.0M28.9M
20120005.4M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Ardelyx Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jul 15, 2024
raab michael
sold
-44,767
5.969
-7,500
president & ceo
Jun 28, 2024
raab michael
sold
-15,222
6.59
-2,310
president & ceo
Jun 21, 2024
blanks robert
sold
-226,290
5.955
-38,000
see remarks
Jun 14, 2024
mott david m
acquired
-
-
17,322
-
Jun 14, 2024
rodgers richard j
acquired
-
-
12,204
-
Jun 14, 2024
bertrand william c jr
acquired
-
-
11,023
-
Jun 13, 2024
raab michael
sold
-232,743
6.6498
-35,000
president & ceo
Jun 13, 2024
raab michael
acquired
34,650
0.99
35,000
president & ceo
Jun 05, 2024
williams laura a
sold
-1,033,080
7.12469
-145,000
chief medical officer
Jun 05, 2024
williams laura a
acquired
275,000
2.75
100,000
chief medical officer

1–10 of 50

Which funds bought or sold ARDX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 18, 2024
WORLD EQUITY GROUP, INC.
added
15.38
19,931
136,359
0.04%
Jul 18, 2024
Good Life Advisors, LLC
new
-
111,150
111,150
0.01%
Jul 18, 2024
Signature Resources Capital Management, LLC
new
-
2,964
2,964
-%
Jul 17, 2024
KBC Group NV
unchanged
-
-
50,000
-%
Jul 16, 2024
SJS Investment Consulting Inc.
unchanged
-
1,100
74,100
0.01%
Jul 16, 2024
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC
added
6.95
12,339
156,499
-%
Jul 12, 2024
SG Americas Securities, LLC
added
283
504,000
679,000
-%
Jul 12, 2024
WEBSTER BANK, N. A.
added
190
7,095
10,745
-%
Jul 10, 2024
CWM, LLC
added
29,830
22,000
22,000
-%
Jul 10, 2024
NBC SECURITIES, INC.
sold off
-100
-1,000
-
-%

1–10 of 46

Are Funds Buying or Selling ARDX?

Are funds buying ARDX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ARDX
No. of Funds

Unveiling Ardelyx Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Jul 10, 2024
state street corp
5.11%
11,965,061
SC 13G/A
Feb 13, 2024
janus henderson group plc
10.6%
24,658,820
SC 13G/A
Feb 13, 2024
vanguard group inc
5.61%
13,026,046
SC 13G
Jan 31, 2024
millennium management llc
0.0%
6,286
SC 13G/A
Jan 30, 2024
state street corp
7.37%
17,102,598
SC 13G/A
Jan 26, 2024
blackrock inc.
7.2%
16,776,055
SC 13G
Jul 10, 2023
state street corp
10.46%
22,437,564
SC 13G
Feb 14, 2023
deep track capital, lp
0%
0
SC 13G/A
Feb 07, 2023
millennium management llc
5.1%
10,162,045
SC 13G
Jan 27, 2023
millennium management llc
5.4%
10,634,329
SC 13G/A

Recent SEC filings of Ardelyx Inc

View All Filings
Date Filed Form Type Document
Jul 17, 2024
4
Insider Trading
Jul 15, 2024
144
Notice of Insider Sale Intent
Jul 10, 2024
SC 13G/A
Major Ownership Report
Jul 02, 2024
8-K
Current Report
Jun 28, 2024
144
Notice of Insider Sale Intent
Jun 28, 2024
4
Insider Trading
Jun 26, 2024
144
Notice of Insider Sale Intent
Jun 25, 2024
4
Insider Trading
Jun 24, 2024
144
Notice of Insider Sale Intent
Jun 21, 2024
144
Notice of Insider Sale Intent

Peers (Alternatives to Ardelyx Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
46.4B
6.8B
-9.08% -2.89%
-7.78
6.94
-64.45% -224.75%
30.1B
2.0B
54.57% 18.06%
-90.59
15.02
75.20% 68.82%
22.5B
216.3K
-0.77% 465779.94%
-2.5K
104.0K
- -8.13%
16.0B
2.5B
-0.07% -3.94%
77.72
6.46
13.74% 186.89%
14.8B
3.8B
7.23% 2.92%
19.84
3.93
8.58% 129.81%
MID-CAP
4.9B
107.9M
-5.14% -24.06%
-8.96
48.09
54.84% -28.31%
4.6B
524.1M
-5.19% 10.95%
-11.05
8.8
394.93% 39.61%
4.0B
251.0M
11.60% 13.99%
-13.6
16.05
73.58% -86.73%
3.5B
240.7M
20.06% -18.70%
-7.43
12.77
-1.03% -213.92%
2.9B
813.8M
19.30% -43.25%
-1.7K
3.6
56.43% 98.83%
1.9B
996.6M
0.36% 71.71%
-4.87
1.95
-26.66% 65.49%
SMALL-CAP
2.0B
411.3M
13.16% 23.83%
30.73
4.86
60.38% -34.49%
618.2M
881.7K
32.05% 709.09%
-18.31
481.06
-77.61% 33.36%
260.1M
4.2M
17.29% 54.94%
-2.08
62.54
-66.30% 48.24%
18.8M
2.1M
-4.39% -80.54%
-0.81
7.61
-13.45% 69.54%

Ardelyx Inc News

Latest updates
Defense World13 hours ago
Seeking Alpha18 Jul 202405:40 pm
American Banking and Market News18 Jul 202405:50 am
Benzinga02 Jul 202407:00 am
Nasdaq02 Jul 202407:00 am
Seeking Alpha02 Jul 202407:00 am

Ardelyx Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32018Q42018Q3
Revenue33.9%46,023,00034,363,00056,391,00022,333,00011,369,00044,178,0004,986,0002,526,000468,0001,029,0001,173,0001,313,0006,582,0001,809,0002,713,0001,836,0001,213,0002,250,0003,013,00085,000172,000
Cost Of Revenue-----1,537,0003,162,000732,000138,00085,000---1,000,0004,000-141,000--600,000-2,000
Gross Profit------------------2,250,0002,413,00085,000170,000
Costs and Expenses11.0%63,573,00057,272,00041,301,00035,468,00035,896,00028,830,50026,134,00028,603,00028,275,00035,302,00043,409,00046,145,00038,587,00029,452,00019,874,00026,043,00022,982,00021,098,00025,102,000--
Operating Expenses-----------------22,982,00021,098,00024,502,00027,461,00023,902,000
  S&GA Expenses11.0%52,994,00047,748,00032,664,00027,186,00026,803,00019,731,00018,667,00018,862,00019,339,00015,334,00019,714,00020,124,00017,131,00011,343,0007,634,0007,038,0007,138,0006,857,0006,922,0005,425,0005,961,000
  R&D Expenses11.1%10,579,0009,524,0008,637,0008,282,0009,093,0009,142,0007,467,0009,741,0008,851,00020,968,00023,695,00026,021,00020,456,00018,105,00012,240,00018,864,00015,844,00014,241,00017,580,00022,036,00017,941,000
EBITDA Margin24.6%-0.36-0.48-0.16-0.62-0.98-1.20-12.12-24.70-36.68-14.94-13.10-9.51-7.56--------
Interest Expenses35.4%2,356,0001,740,0001,107,0001,075,0001,028,000991,000886,000777,000746,000984,0001,216,0001,202,0001,100,0001,314,0001,202,0001,226,0001,357,0001,398,0001,443,000-1,404,000
Income Taxes-63.7%121,000333,000200,000-14,000--6,0002,000-1,0002,0001,0002,000----301,000-2,000-
Earnings Before Taxes7.3%-26,397,000-28,469,0006,829,000-17,121,000-26,759,00010,695,000-22,893,000-26,932,000-28,069,000-36,234,000-43,586,000-45,187,000-33,154,000-28,874,000-18,108,000-24,956,000-22,373,000-19,790,000-23,238,000-27,864,000-24,126,000
EBT Margin22.2%-0.41-0.53-0.20-0.68-1.04-1.29-12.67-25.95-38.43-15.66-13.86-10.09-8.12--------
Net Income7.9%-26,518,000-28,802,0006,629,000-17,121,000-26,773,00010,695,000-22,893,000-26,938,000-28,071,000-36,234,000-43,587,000-45,189,000-33,155,000-28,876,000-18,108,000-24,956,000-22,373,000-19,790,000-23,539,000-27,862,000-24,126,000
Net Income Margin22.1%-0.41-0.53-0.20-0.68-1.05-1.29-12.67-25.95-38.43-15.66-13.86-10.09-8.12--------
Free Cashflow-309.5%-35,872,000-8,761,000-21,661,000-14,830,000-44,809,00014,229,000-25,427,000-31,281,000-27,620,000-39,374,000-35,034,000-35,015,000-44,995,000--------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets15.1%342298289211217190145132129150171205210202199217235260119138166
  Current Assets4.8%258246241162167154120114114134153186205195194212229252111127154
    Cash Equivalents68.4%36.0021.0034.0030.0092.0096.0062.0053.0047.0072.0075.0087.0084.0091.0091.0010010618193.0090.0092.00
  Inventory59.4%79.0049.00-----5.003.00------------
  Net PPE1.0%1.001.001.001.001.001.001.002.002.002.003.003.002.002.002.003.003.003.004.004.005.00
Liabilities46.4%19113198.0088.0092.0092.0078.0079.0065.0067.0089.0087.0079.0075.0067.0071.0068.0073.0070.0069.0074.00
  Current Liabilities12.9%57.0050.0044.0062.0063.0066.0052.0049.0048.0053.0069.0058.0042.0028.0017.0034.0023.0022.0018.0016.0021.00
    LT Debt, Current-------27.0026.0026.0032.00-----------
Shareholder's Equity-9.5%15116719112312598.0067.0053.0064.0083.0081.0011813112613114616818749.0069.0092.00
  Retained Earnings-3.1%-872-846-817-824-806-780-790-767-741-712-676-633-587-554-525-507-482-460-440-417-391
  Additional Paid-In Capital1.1%1,0241,0131,009947932879858821805796758751719681657654651647490486483
Shares Outstanding0.6%23423223221820719916514613110410099.00---------
Float----725---89.00---769---612---126-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-309.7%-35,722-8,718-21,467-14,737-44,79514,284-25,427-31,281-27,620-39,469-34,589-34,276-44,217-17,590-19,877-19,022-24,946-11,137-20,614-27,820-16,913
  Share Based Compensation93.8%7,6163,9303,4893,1992,9121,9261,8483,2543,7223,4712,2623,2193,0872,4342,5272,6742,9482,2123,8791,9231,922
Cashflow From Investing91.3%-2,572-29,567-32,697-59,207-9,7771,441-83215,4742,33222,09618,1338,2342,485-3,5709,59413,417-50,883-55,46123,44825,40529,981
Cashflow From Financing103.8%52,97125,98857,87311,51550,91918,78734,47922,138-63.0014,5134,99928,71734,77021,183798204591155,0582135.00200
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

ARDX Income Statement

2024-03-31
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:  
Total revenues$ 46,023$ 11,369
Cost of goods sold:  
Total cost of goods sold7,1281,537
Operating expenses:  
Research and development10,5799,093
Selling, general and administrative52,99426,803
Total operating expenses63,57335,896
Loss from operations(24,678)(26,064)
Interest expense(2,356)(1,028)
Non-cash interest expense related to the sale of future royalties(1,702)(969)
Other income, net2,3391,302
Loss before provision for income taxes(26,397)(26,759)
Provision for income taxes12114
Net loss$ (26,518)$ (26,773)
Net loss per share of common stock - basic (in dollars per share)$ (0.11)$ (0.13)
Net loss per share of common stock - diluted (in dollars per share)$ (0.11)$ (0.13)
Shares used in computing net loss per share - basic (in shares)233,065,960207,023,127
Shares used in computing net loss per share - diluted (in shares)233,065,960207,023,127
Comprehensive loss:  
Net loss$ (26,518)$ (26,773)
Unrealized (losses) gains on available-for-sale securities(244)34
Comprehensive loss(26,762)(26,739)
Product sales, net  
Revenues:  
Total revenues43,51211,355
Cost of goods sold:  
Total cost of goods sold1,013372
Product supply revenue  
Revenues:  
Total revenues2,1262
Licensing revenue  
Revenues:  
Total revenues1712
Non-cash royalty revenue related to the sale of future royalties  
Revenues:  
Total revenues3680
Other cost of revenue  
Cost of goods sold:  
Total cost of goods sold$ 6,115$ 1,165

ARDX Balance Sheet

2024-03-31
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 36,147$ 21,470
Short-term investments166,431162,829
Accounts receivable28,16222,031
Inventory9,81312,448
Prepaid commercial manufacturing5,51918,925
Prepaid expenses and other current assets11,8678,408
Total current assets257,939246,111
Inventory, non-current69,04537,039
Prepaid commercial manufacturing, non-current4,2354,235
Right-of-use assets4,6415,589
Property and equipment, net1,0191,009
Other assets5,5033,596
Total assets342,382297,579
Current liabilities:  
Accounts payable17,27711,138
Accrued compensation and benefits6,72712,597
Current portion of operating lease liability4,3144,435
Deferred revenue6,5867,182
Accrued expenses and other current liabilities21,99115,041
Total current liabilities56,89550,393
Operating lease liability, net of current portion7781,725
Long-term debt, net of current portion99,83449,822
Deferred revenue, non-current12,1038,644
Deferred royalty obligation related to the sale of future royalties21,88120,179
Total liabilities191,491130,763
Commitments and contingencies (Note 14)
Stockholders’ equity:  
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; no shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively.00
Common stock, $0.0001 par value; 500,000,000 shares authorized; 233,959,744 and 232,453,190 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively.2323
Additional paid-in capital1,023,6101,012,773
Accumulated deficit(872,722)(846,204)
Accumulated other comprehensive (loss) income(20)224
Total stockholders’ equity150,891166,816
Total liabilities and stockholders’ equity$ 342,382$ 297,579
ARDX
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor for the treatment of patients with irritable bowel syndrome with constipation. It also develops XPHOZAH, which is in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia; RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, for adult patients with metabolic acidosis, a serious electrolyte disorder. The company has agreements with Kyowa Kirin, Fosun Pharmaceutical Industrial Development Co. Ltd., and Knight Therapeutics, Inc. for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
 CEO
 WEBSITEardelyx.com
 INDUSTRYBiotechnology
 EMPLOYEES133

Ardelyx Inc Frequently Asked Questions


What is the ticker symbol for Ardelyx Inc? What does ARDX stand for in stocks?

ARDX is the stock ticker symbol of Ardelyx Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Ardelyx Inc (ARDX)?

As of Fri Jul 19 2024, market cap of Ardelyx Inc is 1.29 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ARDX stock?

You can check ARDX's fair value in chart for subscribers.

What is the fair value of ARDX stock?

You can check ARDX's fair value in chart for subscribers. The fair value of Ardelyx Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Ardelyx Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ARDX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Ardelyx Inc a good stock to buy?

The fair value guage provides a quick view whether ARDX is over valued or under valued. Whether Ardelyx Inc is cheap or expensive depends on the assumptions which impact Ardelyx Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ARDX.

What is Ardelyx Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 19 2024, ARDX's PE ratio (Price to Earnings) is -19.59 and Price to Sales (PS) ratio is 8.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ARDX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Ardelyx Inc's stock?

In the past 10 years, Ardelyx Inc has provided -0.102 (multiply by 100 for percentage) rate of return.